Gaelle Quereux

机构：Centre d'Investigation Clinique de Nantes, Nantes Université · ORCID：0000-0002-1739-1701

发表论文 387 篇 · 总被引 5457 次 · h-index 38

代表论文

• Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma (2025 · New England Journal of Medicine · 被引 81)
• Glucagon-Like Peptide-1 Receptor Agonists in Hidradenitis Suppurativa (2025 · JAMA Dermatology · 被引 31)
• Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trial (2025 · Nature Medicine · 被引 16)
• Optimizing Pemphigus Management With Rituximab and Short-Term Relapse Predictors (2025 · JAMA Dermatology · 被引 10)
• Long-Term Efficacy and Safety of Rituximab in Patients With Pemphigus Foliaceus Compared With Pemphigus Vulgaris (2025 · JAMA Dermatology · 被引 8)
• Nivolumab plus relatlimab vs nivolumab alone for the adjuvant treatment of completely resected stage III–IV melanoma: Primary results from RELATIVITY-098. (2025 · Journal of Clinical Oncology · 被引 7)